Park Hee Jung, Ahn Ji Yong, Jung Hwoon-Yong, Lee Jeong Hoon, Jung Kee Wook, Kim Do Hoon, Choi Kee Don, Song Ho June, Lee Gin Hyug, Kim Jin-Ho, Han Seungbong
Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea.
Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
PLoS One. 2016 Dec 12;11(12):e0167615. doi: 10.1371/journal.pone.0167615. eCollection 2016.
The average human life expectancy is increasing worldwide, thus the proportion of elderly gastric cancer patients is also increasing. In this case-control study, we investigated the clinical and oncologic outcomes of gastric cancer in patients over 80 years old.
From January 2004 to December 2010, 291 patients aged over 80 years old (case group) were diagnosed and treated with gastric cancer at Asan Medical Center, Seoul, Korea. From the same period, 291 patients aged 18 to 80 years old were selected as the control group. The clinical findings and clinical outcomes of gastric cancer were retrospectively reviewed and compared between the two groups.
There were significant differences in the overall 5-year survival rate between the case and control groups (30.9% vs. 73.8%, respectively; P<0.001). In patients who received the curative treatment, overall 3- and 5-year survival rates showed 74.3% and 57.9% in case group and 91.6% and 86.5% in the control group. When analysis was confined to resectable elderly patients with a favorable performance, the curative resection group showed significantly better overall 3- and 5-year survival rates than the conservative treatment group (73.7% and 58.8% vs. 29.8% and 0%, respectively).
Although elderly gastric cancer patients show an advanced stage at diagnosis and poor prognosis compared with non-elderly patients, elderly patients with good performance could benefit from curative resection. Thus, the clinical decision whether to undergo curative resection or conservative management should be made on an individualized basis.
全球人类平均预期寿命在不断增加,因此老年胃癌患者的比例也在上升。在这项病例对照研究中,我们调查了80岁以上胃癌患者的临床和肿瘤学结局。
2004年1月至2010年12月,韩国首尔峨山医疗中心诊断并治疗了291例80岁以上的胃癌患者(病例组)。同期,选取291例18至80岁的患者作为对照组。回顾性分析并比较两组胃癌患者的临床特征和临床结局。
病例组和对照组的总体5年生存率存在显著差异(分别为30.9%和73.8%;P<0.001)。接受根治性治疗的患者中,病例组的总体3年和5年生存率分别为74.3%和57.9%,对照组为91.6%和86.5%。当分析仅限于可切除且身体状况良好的老年患者时,根治性切除组的总体3年和5年生存率显著高于保守治疗组(分别为73.7%和58.8%,以及29.8%和0%)。
尽管老年胃癌患者在诊断时分期较晚且预后较非老年患者差,但身体状况良好的老年患者可从根治性切除中获益。因此,关于是否进行根治性切除或保守治疗的临床决策应个体化制定。